84541-38-8

84541-38-8 structure

Name: Raloxifene Bismethyl Ether
Chemical Name: [6-methoxy-2-(4-methoxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone
CAS Number: 84541-38-8
Molecular Formula: C₃₀H₃₁NO₄S
Molecular Weight: 501.63600
Catalog: Research Areas Others
Create Date: 2016-12-06 13:57:22
Modify Date: 2026-07-01 22:24:39
Raloxifene Bismethyl Ether is a metabolite of Raloxifene and an estrogen receptor inactive compound on which both hydroxyl groups are absent[1].

Name	[6-methoxy-2-(4-methoxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone
Synonyms	(4-(2-(PIPERIDIN-1-YL)ETHOXY)PHENYL)(6-METHOXY-2-(4-METHOXYPHENYL)BENZO[B]THIOPHEN-3-YL)METHANONE 6-methoxy-2-(4-methoxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]benzo[b]thiophene Raloxifene Dimethoxy Impurity/ Raloxifene Bismethyl Ether Raloxifene IMpurity: IMpurity C (6-Methoxy-2-(4-Methoxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)Methanone Methanone, [6-methoxy-2-(4-methoxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl] 1-(2-{4-[6-Methoxy-2-(4-methoxy-phenyl)-benzo[b]thiophene-3-carbonyl]-phenoxy}-ethyl)-piperidin (4-(2-(piperidin-1-yl)ethoxy)phenyl)(6-methoxy-2-(4-methoxyphenyl)benzo[b]thiophen-3-yl)methanone Sulfamic Acid Impurity 7 1-(2-{4-[6-methoxy-2-(4-methoxyphenyl)-benzo[b]thiophene-3-carbonyl]-phenoxy}-ethyl)-piperidine [6-Methoxy-2-(4-methoxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone Raloxifene Impurity 2 [6-methoxy-2-(4-methoxyphenyl)benzo[b]thiophene][4-(2-(piperidin-1-yl)ethoxy)phenyl]methanone 6-methoxy-2-(4-methoxyphenyl)-3-[4-(2-piperidinylethoxy)benzoyl]benzo[b]thiophene

Description	Raloxifene Bismethyl Ether is a metabolite of Raloxifene and an estrogen receptor inactive compound on which both hydroxyl groups are absent[1].
Related Catalog	Research Areas >> Others Signaling Pathways >> Others >> Others
In Vitro	Raloxifene Bismethyl Ether has no effect on tissue toughness in the ex vivo beam model[1].
References	[1]. Gallant MA, et al. Bone cell-independent benefits of raloxifene on the skeleton: a novel mechanism for improving bone material properties. Bone. 2014 Apr;61:191-200.